Evolent Health, Inc.
EVH
$9.41
-$0.13-1.36%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 4.05% | -3.98% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.05% | -3.98% | |||
| Cost of Revenue | 5.57% | 0.08% | |||
| Gross Profit | -6.17% | -24.48% | |||
| SG&A Expenses | -29.91% | -0.67% | |||
| Depreciation & Amortization | -1.36% | -0.57% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.52% | -0.03% | |||
| Operating Income | 96.36% | -269.89% | |||
| Income Before Tax | -0.70% | -1,849.34% | |||
| Income Tax Expenses | -81.10% | -160.08% | |||
| Earnings from Continuing Operations | 1.45% | -1,549.69% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 1.45% | -1,549.69% | |||
| EBIT | 96.36% | -269.89% | |||
| EBITDA | 511.22% | -77.53% | |||
| EPS Basic | 2.13% | -388.15% | |||
| Normalized Basic EPS | 74.96% | -876.97% | |||
| EPS Diluted | 2.13% | -388.15% | |||
| Normalized Diluted EPS | 74.96% | -876.97% | |||
| Average Basic Shares Outstanding | 0.15% | 0.15% | |||
| Average Diluted Shares Outstanding | 0.15% | 0.15% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | 0.05% | -1.07% | |||
